Sanofi Revenue 2024. Starting with q1 2024, the. Sanofi reported earnings per share of 97 cents.
Let me now give you some. Revenue in q1 came in at $11.36 billion, 2.6% more than analysts.
Related To Prior Year Sales.
€0.91 (down from €1.60 in 1q.
This Was Above The Analyst Estimate For Eps Of 94 Cents.
Sanofi reported a total revenue of just under 12b eur in the third quarter of the year, which represents a decrease of 4.1% compared to the same quarter a year ago.
Fourth Quarter And Full Year 2023 Results Were Reviewed By Management During A Live Audio Webcast With The Financial Community On February 1St, 2024.
Images References :
Hudson Subsequently Specified That He Expects Sanofi Will Spend Roughly 700 Million Euros More On R&Amp;D In 2024 Than It Did In 2023.
€0.91 (down from €1.60 in 1q.
The Presentation Will Be Followed By A.
It will be impacted in 2024 by our lower business operating income and by the phasing of rebate payments in the u.s.
Second Quarter 2024 Results Will Be Reviewed By Management During A Live Audio Webcast With The Financial Community On July 25 Th, 2024.